Data gathered: November 27
AI Stock Analysis - TC BioPharm (TCBP)
Analysis generated October 29, 2024. Powered by Chat GPT.
TC BioPharm is a biotechnology company focused on advancing innovative immuno-oncology and infectious disease therapies using cutting-edge T cell-based technologies. Their mission is to leverage the natural ability of T cells to seek and destroy cancer cells, offering hope for improved treatments for patients facing life-threatening diseases. The company is committed to rigorous scientific research and clinical trials to ensure the efficacy and safety of their products.
Stock Alerts - TC BioPharm (TCBP)
 |
TC BioPharm | November 27 Price is down by -5.8% in the last 24h. |
|
TC BioPharm | November 26 Price is down by -5.3% in the last 24h. |
|
TC BioPharm | November 25 Price is up by 7.4% in the last 24h. |
|
TC BioPharm | November 21 Price is down by -5.2% in the last 24h. |
Alternative Data for TC BioPharm
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 85 | Sign up | Sign up | Sign up |
| Webpage traffic | 2,000 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 21 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 6,077 | Sign up | Sign up | Sign up |
| Twitter Followers | 937 | Sign up | Sign up | Sign up |
| Twitter Mentions | 17 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 53 | Sign up | Sign up | Sign up |
About TC BioPharm
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform.
| Price | $0.60 |
| Target Price | Sign up |
| Volume | 424,260 |
| Market Cap | $360,000 |
| Year Range | $0.6 - $19.5 |
| Dividend Yield | 0% |
| Analyst Rating | 0% buy |
| Industry | Biotechnology |
In the news
 |
TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® GrantNovember 11 - Yahoo |
 |
Contrasting TC Biopharm (NASDAQ:TCBP) and Moderna (NASDAQ:MRNA)November 3 - ETF Daily News |
|
TCBP Provides Shareholder Update and Highlights Recent Milestone AchievementsOctober 29 - Yahoo |
|
TCBP Responds to False Social Media ClaimOctober 24 - Yahoo |
 |
TCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox TherapeuticOctober 22 - Investing.com |
 |
TC Biopharm (NASDAQ:TCBP) Shares Up 14.8% - Should You Buy?October 5 - Biztoc.com |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '24 | 0 | 1.1M | -1.1M | -2M | -2M | |
| Q1 '24 | 0 | 2.2M | -2.2M | -3.3M | -3.4M | -27.950 |
| Q4 '23 | 0 | 0 | 0 | 0 | 0 | |
| Q2 '23 | 0 | 1.5M | -1.5M | 1M | -3.6M | |
| Q1 '23 | 0 | 2.2M | -2.2M | -630,000 | -4.2M |
Insider Transactions View All
| Renaissance Capital Partners Ltd filed to buy 70,000 shares at $0. January 11 '23 |
| Randall Kenneth Edward filed to buy 70,000 shares at $0. January 11 '23 |
| Randall Mark Edward filed to buy 70,000 shares at $0. January 11 '23 |
| Randall Kenneth Edward filed to buy 70,000 shares at $0. January 11 '23 |
| Randall Mark Edward filed to buy 70,000 shares at $0. January 11 '23 |
Similar companies
Read more about TC BioPharm (TCBP) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews & linkedin employees.
What is the Market Cap of TC BioPharm?
The Market Cap of TC BioPharm is $360,000.
What is the current stock price of TC BioPharm?
Currently, the price of one share of TC BioPharm stock is $0.60.
How can I analyze the TCBP stock price chart for investment decisions?
The TCBP stock price chart above provides a comprehensive visual representation of TC BioPharm's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling TC BioPharm shares. Our platform offers an up-to-date TCBP stock price chart, along with technical data analysis and alternative data insights.
Does TCBP offer dividends to its shareholders?
As of our latest update, TC BioPharm (TCBP) does not offer dividends to its shareholders. Investors interested in TC BioPharm should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of TC BioPharm?
Some of the similar stocks of TC BioPharm are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.